New therapeutical horizons in the management of postmenopausal osteoporosis
S Migliaccio, R Fornari, EA Greco, L Di Luigi… - Aging Clinical and …, 2013 - Springer
Osteoporosis is a bone metabolic disease characterized by a compromised skeletal fragility,
leading to an increased risk of developing spontaneous and traumatic fractures. This …
leading to an increased risk of developing spontaneous and traumatic fractures. This …
[引用][C] Current therapies and future directions in osteoporosis management
V SIBILIA, C NETTI - Pharmacological research, 1996 - Elsevier
Inthelastfewyears, ithasbeenrecognizedthatinvol- Bone is characterized by a continuous
lifelong renewal process (bone remodeling) with the resorputional osteoporosis …
lifelong renewal process (bone remodeling) with the resorputional osteoporosis …
Perspectives on osteoporosis therapies
E Cairoli, VV Zhukouskaya, C Eller-Vainicher… - Journal of …, 2015 - Springer
Osteoporosis is a skeletal disease which predisposes to fragility fractures with high morbidity
and economic impact, and, therefore, the goal of any osteoporosis treatment is to reduce the …
and economic impact, and, therefore, the goal of any osteoporosis treatment is to reduce the …
Therapeutic treatments for osteoporosis—which combination of Pills is the best among the bad?
CH Tonk, SH Shoushrah, P Babczyk… - International journal of …, 2022 - mdpi.com
Osteoporosis is a chronical, systemic skeletal disorder characterized by an increase in bone
resorption, which leads to reduced bone density. The reduction in bone mineral density and …
resorption, which leads to reduced bone density. The reduction in bone mineral density and …
Treatment needs and current options for postmenopausal osteoporosis
Introduction: Osteoporosis is a chronic, skeletal disorder characterized by compromised
bone strength and increased risk of fractures, affecting up to 50% of postmenopausal …
bone strength and increased risk of fractures, affecting up to 50% of postmenopausal …
Pharmacological management of osteoporosis
SE Papapoulos - Aging Clinical and Experimental Research, 1998 - Springer
Pharmacological interventions for the prevention of fractures in patients with osteoporosis
aim mainly at correcting the bone remodelling imbalance by either reducing bone resorption …
aim mainly at correcting the bone remodelling imbalance by either reducing bone resorption …
The challenge: fracture treatment in osteoporotic bone
E Schneider, J Goldhahn, P Burckhardt - Osteoporosis International, 2005 - Springer
Research in osteoporosis has focused so far on the pathophysiology, epidemiology,
diagnosis, and monitoring of the disease, as well as on its metabolic and cellular basis and …
diagnosis, and monitoring of the disease, as well as on its metabolic and cellular basis and …
Pharmacological therapy of osteoporosis: a systematic current review of literature
Osteoporosis is the most common bone disease affecting millions of people worldwide,
particularly in elderly or in post-menopausal women. The pathogenesis is useful to …
particularly in elderly or in post-menopausal women. The pathogenesis is useful to …
[图书][B] New Horizons in Osteoporosis Management
Y El Miedany, E Miedany - 2022 - Springer
Advances in the understanding of bone health and osteoporosis management in the last
three decades have exceeded that of most other chronic diseases of aging. Clinicians …
three decades have exceeded that of most other chronic diseases of aging. Clinicians …
Pharmacological therapy of osteoporosis: what's new?
Osteoporosis and fragility fractures are relevant health issues because of their impact in
terms of morbidity, mortality, and socioeconomic burden. Despite this alarming scenario …
terms of morbidity, mortality, and socioeconomic burden. Despite this alarming scenario …